BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25262266)

  • 1. Differences in sex-related bleeding and outcomes after percutaneous coronary intervention: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) registry.
    Othman H; Khambatta S; Seth M; Lalonde TA; Rosman HS; Gurm HS; Mehta RH
    Am Heart J; 2014 Oct; 168(4):552-9. PubMed ID: 25262266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radial PCI and the obesity paradox: Insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
    McDonagh JR; Seth M; LaLonde TA; Khandewal AK; Wohns DH; Dixon SR; Gurm HS
    Catheter Cardiovasc Interv; 2016 Feb; 87(2):211-9. PubMed ID: 26010906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences in adverse outcomes after contemporary percutaneous coronary intervention: an analysis from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) percutaneous coronary intervention registry.
    Duvernoy CS; Smith DE; Manohar P; Schaefer A; Kline-Rogers E; Share D; McNamara R; Gurm HS; Moscucci M
    Am Heart J; 2010 Apr; 159(4):677-683.e1. PubMed ID: 20362729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age and sex differences in inhospital complication rates and mortality after percutaneous coronary intervention procedures: evidence from the NCDR(®).
    Lichtman JH; Wang Y; Jones SB; Leifheit-Limson EC; Shaw LJ; Vaccarino V; Rumsfeld JS; Krumholz HM; Curtis JP
    Am Heart J; 2014 Mar; 167(3):376-83. PubMed ID: 24576523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of percutaneous coronary intervention following recent surgery.
    Hoyt JR; Seth M; Hanson I; Dixon S; Share D; Lalonde T; Wohns D; Moscucci M; Gurm HS
    Am J Cardiol; 2013 Nov; 112(10):1580-5. PubMed ID: 23998350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous Coronary Intervention in Patients With a History of Gastrointestinal Bleeding (From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium).
    Meloche C; Seth M; Madder RD; Kurlander JE; Yaser J; Chattahi J; Collins J; Lingam N; Arora D; Gurm HS; Sukul D
    Am J Cardiol; 2021 Sep; 155():9-15. PubMed ID: 34325106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of acute kidney injury after percutaneous coronary interventions using radial versus femoral vascular access: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.
    Kooiman J; Seth M; Dixon S; Wohns D; LaLonde T; Rao SV; Gurm HS
    Circ Cardiovasc Interv; 2014 Apr; 7(2):190-8. PubMed ID: 24569598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary percutaneous coronary intervention at centers with and without on-site surgical support: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
    Afana M; Gurm HS; Seth M; Frazier KM; Fielding S; Koenig GC
    Am Heart J; 2018 Jan; 195():99-107. PubMed ID: 29224652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Underutilization of Radial Access in Patients Undergoing Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.
    Howe MJ; Seth M; Riba A; Hanzel G; Zainea M; Gurm HS
    Circ Cardiovasc Interv; 2015 May; 8(5):. PubMed ID: 25922417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical outcomes of percutaneous coronary intervention performed without pre-procedural aspirin.
    Kenaan M; Seth M; Aronow HD; Wohns D; Share D; Gurm HS;
    J Am Coll Cardiol; 2013 Dec; 62(22):2083-9. PubMed ID: 24055844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retroperitoneal hematoma after percutaneous coronary intervention: prevalence, risk factors, management, outcomes, and predictors of mortality: a report from the BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) registry.
    Trimarchi S; Smith DE; Share D; Jani SM; O'Donnell M; McNamara R; Riba A; Kline-Rogers E; Gurm HS; Moscucci M;
    JACC Cardiovasc Interv; 2010 Aug; 3(8):845-50. PubMed ID: 20723857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of sex with outcomes among patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction in the contemporary era: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
    Jackson EA; Moscucci M; Smith DE; Share D; Dixon S; Greenbaum A; Grossman PM; Gurm HS
    Am Heart J; 2011 Jan; 161(1):106-112.e1. PubMed ID: 21167341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex-related analysis of short- and long-term clinical outcomes and bleeding among patients treated with primary percutaneous coronary intervention: an evaluation of the RISK-PCI data.
    Mrdovic I; Savic L; Asanin M; Cvetinovic N; Brdar N; Djuricic N; Stepkovic M; Marinkovic J; Perunicic J
    Can J Cardiol; 2013 Sep; 29(9):1097-103. PubMed ID: 23462375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bleeding after percutaneous coronary intervention in women and men matched for age, body mass index, and type of antithrombotic therapy.
    Ndrepepa G; Schulz S; Neumann FJ; Byrne RA; Hoppmann P; Cassese S; Ott I; Fusaro M; Ibrahim T; Tada T; Richardt G; Laugwitz KL; Schunkert H; Kastrati A
    Am Heart J; 2013 Sep; 166(3):534-40. PubMed ID: 24016504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Of Bleeding Avoidance Strategies with age-related bleeding and In-hospital mortality in patients undergoing percutaneous coronary Interventions.
    Khambatta S; Othman H; Seth M; Lalonde T; Rosman HS; Gurm HS; Mehta RH;
    Cardiovasc Revasc Med; 2016 Jun; 17(4):233-40. PubMed ID: 26994504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between patient race, treatment, and outcomes of patients undergoing contemporary percutaneous coronary intervention: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
    Khambatta S; Seth M; Rosman HS; Share D; Aronow HD; Moscucci M; Lalonde T; Dixon SR; Gurm HS
    Am Heart J; 2013 Jun; 165(6):893-901.e2. PubMed ID: 23708159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of sex on morbidity and mortality rates after lower extremity interventions for peripheral arterial disease: observations from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.
    Jackson EA; Munir K; Schreiber T; Rubin JR; Cuff R; Gallagher KA; Henke PK; Gurm HS; Grossman PM
    J Am Coll Cardiol; 2014 Jun; 63(23):2525-2530. PubMed ID: 24747101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preprocedural statin use in patients undergoing percutaneous coronary intervention.
    Kenaan M; Seth M; Aronow HD; Naoum J; Wunderly D; Mitchiner J; Moscucci M; Gurm HS;
    Am Heart J; 2014 Jul; 168(1):110-6.e3. PubMed ID: 24952867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significantly improved vascular complications among women undergoing percutaneous coronary intervention: a report from the Northern New England Percutaneous Coronary Intervention Registry.
    Ahmed B; Piper WD; Malenka D; VerLee P; Robb J; Ryan T; Herne M; Phillips W; Dauerman HL
    Circ Cardiovasc Interv; 2009 Oct; 2(5):423-9. PubMed ID: 20031752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiology and outcomes of percutaneous coronary intervention before high-risk noncardiac surgery in contemporary practice: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) Registry.
    Muthappan P; Smith D; Aronow HD; Eagle K; Wohns D; Fox J; Share D; Gurm HS
    J Am Heart Assoc; 2014 May; 3(3):e000388. PubMed ID: 24820654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.